Do you need a Washington, DC Abilify lawyer? Contact one of our Washington, DC Abilify lawyers now.
Abilify - MSN Newsfeeds
- Bennington Banner - Last July's list for the Springfield prison showed 77 more prescriptions had been written for other anti-psychotic drugs, including Zyprexa, Risperdal and Abilify. * At Southeast State Correctional Facility in Windsor, a women's prison, nearly a ...
- Health 24 - They include Risperidone, Quetiapine, Olanzapine, Aripiprazole and Clozapine. Although they are more expensive, their improved efficacy means less hospitalization and better functioning of the individual, which is priceless. Research continues to ...
- Albany Democrat-Herald - While in the jail, Webster’s lawsuit alleges, an unknown county mental health worker prescribed Abilify for her because of “alleged emotional upset and related concerns because of her incarceration.” Her lawsuit says that she never had any ...
- Newark Star-Ledger - Bristol-Myers Squibb yesterday announced its application to market Abilify for schizophrenia to teenagers was granted priority review by the Food and Drug Administration. If approved, it would keep Bristol-Myers in step with its competitors and ...
- Washington Post - Food and Drug Administration warned doctors about atypical antipsychotics, specifically olanzapine (Zyprexa), aripiprazole (Abilify), risperidone (Risperdal), and quetiapine (Seroquel). Fifteen of 17 studies of elderly patients with dementia -- which ...
- Crain's New York Business - Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Co. said Tuesday that the Food and Drug Administration approved a priority review of their antipsychotic drug Abilify as a potential treatment for teenagers with schizophrenia. Abilify would become ...
- HealthScout - Food and Drug Administration warned doctors about atypical antipsychotics, specifically olanzapine ( Zyprexa ), aripiprazole ( Abilify ), risperidone ( Risperdal ), and quetiapine ( Seroquel ). Fifteen of 17 studies of elderly patients with dementia -- which ...
- StreetInsider.com - ... Tentative FDA Approval for Generic Risperdal Bristol-Myers Squibb (BMY) and Otsuka Pharma Receive Priority Review for ABILIFY ... GlaxoSmithKline (NYSE: GSK ) announced final results of a Phase II proof-of-concept clinical trial of its investigational ...
- Forbes - Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Co. said Tuesday the Food and Drug Administration granted Abilify a priority review for expanded use in teenagers. The decision means the FDA will review the antipsychotic drug candidate with a six ...
- MSN MoneyCentral - - Otsuka-sponsored Study Evaluated Use of ABILIFY in Patients Ages 13-17 - TOKYO and PRINCETON, N.J., JUNE 5 /PRNewswire/ -- Otsuka Pharmaceutical Co., Ltd., and Bristol-Myers Squibb Company BMY announced today that the U.S. Food and Drug ...
- StreetInsider.com - Bristol-Myers Squibb (BMY) and Otsuka Pharma Receive Priority Review for ABILIFY From FDA Health Canada Approves PLAVIX (BMY) for All Types of Heart Attacks NovaDel (NVD) Announces Positive Data on Zolpidem Repros Therapeutics (RPRX) Announces ...
- Motley Fool - The $16 billion anti-psychotic drug market, composed of compounds like Abilify and Eli Lilly 's (NYSE: LLY ) Zyprexa, is a tough and highly competitive market. What makes this market even more cutthroat is that none of the atypical anti-psychotics have ...
- News-Medical.Net - The researchers, in collaboration with Lipomics Technologies, measured 300 different lipids in blood drawn from 50 patients with schizophrenia before and after treatment with the atypical antipsychotic drugs olanzapine, risperidone or aripiprazole ...
- INS News - Last year, drugmaker Bristol-Myers Squibb agreed to pay $499 million to settle federal investigations into its pricing, sales and marketing practices related to its schizophrenia drug Abilify, and Schering-Plough paid $435 million to settle federal ...
- Senior Journal - The advisory applies to such antipsychotic drugs as Abilify (aripiprazole), Zyprexa (olanzapine), Seroquel (quetiapine), Risperdal (risperidone), Clozaril (clozapine) and Geodon (ziprasidone). Symbyax, which is approved for treatment of ...
- New York Times - These best-selling drugs, including Risperdal, Seroquel, Zyprexa, Abilify and Geodon, are now being prescribed to more than half a million children in the United States to help parents deal with behavior problems despite profound risks and almost no ...
- HealthCentral.com - lamictal has done wonders for friends of mine. depakote is a stop gap...in my opinion. and if effexor works take it?! you may also want to try abilify, that's what i take; that is, if you can get your hands on the expensive stuff! take care...don't ...
- Earthtimes - Bright spots were Avapro, whose sales rose 16 percent to $270 million, and schizophrenia treatment Abilify, whose revenue jumped 29 percent to $366 million, helped by its favorable safety profile. Cancer drug Erbitux, sold in partnership with ImClone ...
- New York Observer - GEORGE: I don’t know. I don’t know if this is something about technology and the modern world—but, who knows, maybe ... GEORGE: Um, I took that one pill [Abilify] here, and then I stopped taking it. ...
- Boston Globe - WOODCLIFF LAKE, N.J. -- Barr Pharmaceuticals Inc. confirmed Tuesday that its subsidiary has initiated a challenge to the patent held by Otsuka Pharmaceutical Co. for its schizophrenia drug, Abilify. The subsidiary, Barr Laboratories , triggered a ...
Do you need a Washington, DC Abilify lawyer? Contact one of our Washington, DC Abilify lawyers now.
Pages: 1 2 3 4 5 Next
